The use of stents in contemporary urology

Current Opinion in Urology

Volumn 14, Issue 2, 2004, Pages 111-115

  Chew, Ben H ^a   Knudsen, Bodo E ^a   Denstedt, John D ^a,b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b ST JOSEPH S HEALTH CENTRE   (Canada)

Author keywords

Lithotripsy; Stent; Ureter; Ureteral obstruction; Urolithiasis

Indexed keywords

DEVICE INFECTION; EXTRACORPOREAL LITHOTRIPSY; HEMATURIA; HUMAN; NONHUMAN; PATIENT CARE; PATIENT SATISFACTION; PRIORITY JOURNAL; PYELOPLASTY; PYELOTOMY; QUALITY OF LIFE; REVIEW; TREATMENT OUTCOME; URETER STENT; URETEROPELVIC JUNCTION OBSTRUCTION; URETEROSCOPY; UROLITHIASIS;

BIOCOMPATIBLE MATERIALS; HUMANS; LITHOTRIPSY; QUALITY OF LIFE; STENTS; URETERAL CALCULI; URETEROSCOPY;

EID: 1542284702     PISSN: 09630643     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042307-200403000-00011     Document Type: Review

References (46)

1. Bloom DA, Clayman RV, McDougal E. Stents and related terms: a brief history. Urology 1999; 54:767-771.
2. Brewer AV, Elbahnasy AM, Bercowsky E, et al. Mechanism of ureteral stent flow: a comparative in vivo study. J Endourol 1999; 13:269-271.
3. Olweny EO, Landman J, Andreoni C, et al. Evaluation of the use of a biodegradable ureteral stent after retrograde endopyelotomy in a porcine model. J Urol 2002; 167:2198-2202.
4. Kinn AC, Lykkeskov-Andersen H. Impact on ureteral peristalsis in a stented ureter: an experimental study in the pig. Urol Res 2002; 30:213-218.
5. Pearle MS, Pierce HL, Miller GL, et al. Optimal method of urgent decompression of the collecting system for obstruction and infection due to ureteral calculi. J Urol 1998; 160:1260-1264.
6. Mokhmalji H, Braun PM, Martinez Portillo FJ, et al. Percutaneous nephrostomy versus ureteral stents for diversion of hydronephrosis caused by stones: a prospective, randomized clinical trial. J Urol 2001; 165:1088-1092.
7. Libby JM, Meacham RB, Griffith DP. The role of silicone ureteral stents in extracorporeal shock wave lithotripsy of large renal calculi. J Urol 1988; 139:15-17.
8. Sulaiman MN, Buchholz NP, Clark PB. The role of ureteral stent placement in the prevention of steinstrasse. J Endourol 1999; 13:151-155.
9. Preminger GM, Kettelhut MC, Elkins SL, et al. Ureteral stenting during extracorporeal shock wave lithotripsy: help or hindrance? J Urol 1989; 142:32-36.
10. Al-Awadi KA, Abdul HH, Kehinde EO, Al Tawheed A. Steinstrasse: a comparison of incidence with and without J stenting and the effect of J stenting on subsequent management. BJU Int 1999; 84:618-621.
11. Bierkens AF, Hendrikx AJ, Lemmens WA, Debruyne FM. Extracorporeal shock wave lithotripsy for large renal calculi: the role of ureteral stents. A randomized trial. J Urol 1991; 145(4):699-702.
12. Chandhoke PS, Barqawi AZ, Wernecke C, Chee-Awai RA. A randomized outcomes trial of ureteral stents for extracorporeal shock wave lithotripsy of solitary kidney or proximal ureteral stones. J Urol 2002; 167:1981-1983.
13. Delakas D, Daskalopoulos G, Metaxari M, et al. Management of ureteral stones in pediatric patients. J Endourol 2001; 15:675-680.
14. Demirkesen O, Tansu N, Yaycioglu O, et al. Extracorporeal shockwave lithotripsy in the pediatric population. J Endourol 1999; 13:147-150.
15. Gofrit ON, Pode D, Meretyk S, et al. Is the pediatric ureter as efficient as the adult ureter in transporting fragments following extracorporeal shock wave lithotripsy for renal calculi larger than 10 mm? J Urol 2001; 166:1862-1864.
16. Al Busaidy SS, Prem AR, Medhat M. Pediatric staghorn calculi: the role of extracorporeal shock wave lithotripsy monotherapy with special reference to ureteral stenting. J Urol 2003; 169:629-633.
17. Joshi HB, Okeke A, Newns N, et al. Characterization of urinary symptoms in patients with ureteral stents. Urology 2002; 59:511-516.
18. Joshi HB, Stainthorpe A, MacDonagh RP, et al. Indwelling ureteral stents: evaluation of symptoms, quality of life and utility. J Urol 2003; 169:1065-1069.
19. Joshi HB, Newns N, Stainthorpe A, et al. Ureteral stent symptom questionnaire: development and validation of a multidimensional quality of life measure. J Urol 2003; 169:1060-1064. The first validated questionnaire regarding the quality of life of stented patients. Will be an invaluable tool to objectively evaluate new stents for clinical use.
20. Joshi HB, Newns N, Stainthorpe A, et al. The development and validation of a patient-information booklet on ureteric stents. BJU Int 2001; 88:329-334. http://www.bui.ac.uk/patientinformation/uretericstent/uretericfront.htm
21. Denstedt JD, Wollin TA, Sofer M, et al. A prospective randomized controlled trial comparing nonstented versus stented ureteroscopic lithotripsy. J Urol 2001; 165:1419-1422.
22. Erturk E, Sessions A, Joseph JV. Impact of ureteral stent diameter on symptoms and tolerability. J Endourol 2003; 17:59-62.
23. Hosking DH, McColm SE, Smith WE. Is stenting following ureteroscopy for removal of distal ureteral calculi necessary? J Urol 1999; 161:48-50.
24. Teichman JM, Vassar GJ, Bishoff JT, Bellman GC. Holmium:YAG lithotripsy yields smaller fragments than lithoclast, pulsed dye laser or electrohydraulic lithotripsy. J Urol 1998; 159:17-23.
25. Byrne RR, Auge BK, Kourambas J, et al. Routine ureteral stenting is not necessary after ureteroscopy and ureteropyeloscopy: a randomized trial. J Endourol 2002; 16:9-13.
26. Hollenbeck BK, Schuster TG, Faerber GJ, Wolf JS Jr. Routine placement of ureteral stents is unnecessary after ureteroscopy for urinary calculi. Urology 2001; 57:639-643.
27. Chen YT, Chen J, Wong WY, et al. Is ureteral stenting necessary after uncomplicated ureteroscopic lithotripsy? A prospective, randomized controlled trial. J Urol 2002; 167:1977-1980.
28. Borboroglu PG, Amling CL, Schenkman NS, et al. Ureteral stenting after ureteroscopy for distal ureteral calculi: a multi-institutional prospective randomized controlled study assessing pain, outcomes and complications. J Urol 2001; 166:1651-1657.
29. Netto NR Jr, Ikonomidis J, Zillo C. Routine ureteral stenting after ureteroscopy for ureteral lithiasis: is it really necessary? J Urol 2001; 166:1252-1254.
30. Mandhani A, Kapoor R, Zaman W, et al. Is a 2-week duration sufficient for stenting in endopyelotomy? J Urol 2003; 169:886-889.
31. Kerbl K, Chandhoke PS, Figenshau RS, et al. Effect of stent duration on ureteral healing following endoureterotomy in an animal model. J Urol 1993; 150:1302-1305.
32. Smith KE, Holmes N, Lieb JI, et al. Stented versus nonstented pediatric pyeloplasty: a modern series and review of the literature. J Urol 2002; 168:1127-1130.
33. Barbalias GA, Liatsikos EN, Kalogeropoulou C, et al. Externally coated ureteral metallic stents: an unfavorable clinical experience. Eur Urol 2002; 42:276-280.
34. Beiko DT, Knudsen BE, Watterson JD, Denstedt JD. Biomaterials in urology. Curr Urol Rep 2003; 4:51-55.
35. Beiko DT, Knudsen BE, Denstedt JD. Advances in ureteral stent design. J Endourol 2003; 17:195-199.
36. Denstedt JD, Reid G, Sofer M. Advances in ureteral stent technology. World J Urol 2000; 18:237-242.
37. Denstedt JD, Wollin TA, Reid G. Biomaterials used in urology: current issues of biocompatibility, infection, and encrustation. J Endourol 1998; 12:493-500.
38. Lingeman JE, Preminger GM, Berger Y, et al. Use of a temporary ureteral drainage stent after uncomplicated ureteroscopy: results from a phase II clinical trial. J Urol 2003; 169:1682-1688.
39. Lingeman JE, Schulsinger DA, Kuo RL. Phase I trial of a temporary ureteral drainage stent. J Endourol 2003; 17:169-171.
40. Beiko DT, Watterson JD, Knudsen BE, et al. A double-blinded prospective randomized controlled trial assessing the safety and efficacy of intravesical agents for ureteral stent symptoms following extracorporeal shockwave lithotripsy. J Endourol (in press).
41. Watterson JD, Cadieux PA, Beiko DT, et al. Oxalate-degrading enzymes from Oxalobacter formigenes: a novel device coating to reduce urinary tract biomaterial-related encrustation. J Endourol 2003; 17:269-274. Won the first prize essay at the 20th World Congress of Endourology. Coated silicone discs were implanted into rabbit bladders and those encoated with the enzyme from the gut colonizing bacterium, Oxalobacter formigenes, resisted encrustation compared with control discs. This may lead to enzyme-encoated stents which will reduce encrustation and allow longer indwelling times.
42. Kehinde EO, Rotimi VO, Al Awadi KA, et al. Factors predisposing to urinary tract infection after J ureteral stent insertion. J Urol 2002; 167:1334-1337.
43. Reid G, Habash M, Vachon D, et al. Oral fluoroquinolone therapy results in drug adsorption on ureteral stents and prevention of biofilm formation, Int J Antimicrob Agents 2001; 17:317-319.
44. Paick SH, Park HK, Oh SJ, Kim HH. Characteristics of bacterial colonization and urinary tract infection after indwelling of double-J ureteral stent. Urology 2003; 62:214-217.
45. Pauer W, Lugmayr H. Metallic wallstents: a new therapy for extrinsic ureteral obstruction. J Urol 1992; 148 (2 Pt 1):281-284.
46. Hekimoglu B, Men S, Pinar A, et al. Urothelial hyperplasia complicating use of metal stents in malignant ureteral obstruction. Eur Radiol 1996; 6:675-681.